NCT04233632 is a NA clinical trial of FC2 Condom in Pregnancy Prevention, sponsored by Prof Mags Beksinska.

Who is sponsoring NCT04233632?

NCT04233632 is sponsored by Prof Mags Beksinska.

What drugs are being tested in NCT04233632?

Interventions in NCT04233632: FC2 Condom, Cupid Condom, Cupid 2 Condom.

What condition does NCT04233632 study?

NCT04233632 studies Pregnancy Prevention.

Is NCT04233632 still recruiting?

NCT04233632 is currently completed. Last updated 19 January 2022.

Last reviewed 2022-01-19 · How we verify

NCT04233632

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Comparative Study of the Contraceptive Efficacy of the Cupid, Cupid 2 and FC2 Female Condom

Completed NA Last updated 19 January 2022

What this trial tests

NA trial testing FC2 Condom in Pregnancy Prevention in 400 participants. Completed in 10 November 2021.

Timeline

27 November 2019

Primary endpoint
10 November 2021

10 November 2021

Quick facts

Lead sponsor	Prof Mags Beksinska
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	prevention
Enrollment	400
Start date	27 November 2019
Primary completion	10 November 2021
Estimated completion	10 November 2021
Sites	1 location across South Africa

Drugs / interventions tested

FC2 Condom
Cupid Condom
Cupid 2 Condom

Conditions studied

Pregnancy Prevention — all drugs for Pregnancy Prevention →

Sponsor

Prof Mags Beksinska

Who can join

Adults 18 to 40, female only, with Pregnancy Prevention. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This research study aims to assess the effectiveness of three female condoms \[Cupid, Cupid 2 and Female Condom 2(FC2)\] for the prevention of pregnancy among women choosing the female condom (FC) as their method of fertility regulation. Participants will be followed-up monthly for up to seven months. A daily diary will be used to record menstrual pattern, acts of intercourse and details of condom usage.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Female condom color and scent preference in Durban, South Africa.
Beksinska M, Smit J, Mona A, Maphumulo V, et al · · 2023 · cited 1× · PMID 37554547 · DOI 10.1016/j.conx.2023.100095

Verify or expand the search:

Other recruiting trials for Pregnancy Prevention

Currently open trials in the same condition.

NCT06306131 — Phase II Study of Ovulation in Obese Women · Phase 2 · recruiting
NCT05695352 — Oral Levonorgestrel Plus Meloxicam, IG-002 Delays Ovulation in Normal Menstruating Women by Seven Days · Phase 2 · recruiting

Other Prof Mags Beksinska trials

Trials by the same sponsor.

NCT04881877 — Functional Performance and Acceptability Study of Synthetic Nitrile, and Latex Graphene, Compared to Standard Latex Male · NA · completed
NCT04076774 — A Functional Performance Study of The Wondaleaf Female Condom · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04233632 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Prof Mags Beksinska
Last refreshed: 19 January 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04233632.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing